Status:
COMPLETED
Preoperative Immunonutrition and Cardiac Patients
Lead Sponsor:
Assiut University
Conditions:
Cardiac Function
Eligibility:
All Genders
18-60 years
Phase:
PHASE2
PHASE3
Brief Summary
With the progress of cardiac surgery, the indication of cardiac valve replacement has been extended to include severely ill patients, even those with cardiac cachexia caused by long-standing mitral va...
Detailed Description
Eligibility and type of the study: This randomized clinical trial will be conducted at Assiut University Hospital from March 2018 until March 2019 after approval from the Institutional Ethics Committe...
Eligibility Criteria
Inclusion
- Both sex
- Age: 18-60 years.
- Valvular heart disease .
- ASA II,III
- Non-diabetic.
- Elective surgery.
Exclusion
- Pre-existing renal disease(creatinine3.5mg/dl or dialysis)
- Diabetic.
- Off pump surgery.
- Long CBP time \>120 min .
- Previous cardiac surgery.
- Hepatic failure or established cirrhosis.
- Emergency surgery
Key Trial Info
Start Date :
August 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 31 2022
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03445221
Start Date
August 1 2018
End Date
March 31 2022
Last Update
August 16 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assiut university hospital
Asyut, Egypt, 71515